Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy

Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy

Background The current study aimed to evaluate the serum pretreatment lactate dehydrogenase (LDH) and overall survival (OS) in small cell lung cancer (SCLC) patients who received first‐line platinum‐containing chemotherapy. Methods A total of 234 SCLC patients, who received first‐line platinum‐based...

Full description

Bibliographic Details
Main Authors: Man He, Xiaorui Chi, Xinyan Shi, Yang Sun, Xue Yang, Leirong Wang, Bingrui Wang, Hongmei Li
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Thoracic Cancer
Subjects:
LDH
OS
prognosis
SCLC
Online Access:https://doi.org/10.1111/1759-7714.13581

Similar Items

Similar Items